Who is sponsoring NCT01978938?

NCT01978938 is sponsored by Tetraphase Pharmaceuticals, Inc.

What drugs are being tested in NCT01978938?

Interventions: Eravacycline, Levofloxacin.

What is the status of NCT01978938?

NCT01978938 is currently COMPLETED.

Last reviewed 2022-01-11 · How we verify

Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections

NCT01978938 PHASE3 COMPLETED Results posted

This is a phase 3, randomized, double-blind, double-dummy, multicenter, prospective study to assess the efficacy and safety of eravacycline compared with levofloxacin in participants with complicated urinary tract infections (cUTI).

Details

Lead sponsor	Tetraphase Pharmaceuticals, Inc
Phase	PHASE3
Status	COMPLETED
Enrolment	908
Start date	Mon Oct 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Aug 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

cUTI

Interventions

Eravacycline
Levofloxacin

Countries

Georgia, Italy, Colombia, South Africa, Russia, Greece, Ukraine, Estonia, Israel, Hungary, Mexico, Moldova, Poland, Romania, Bulgaria, Latvia, United States, Czechia